Skip to main content
Jean Cadet, MD, Psychiatry, Baltimore, MD

JeanLudCadetMD(He/Him)

Psychiatry Baltimore, MD

Addiction, Neuropsychiatry, Psychopharmacology

Chief, Molecular Neuropsychiatry Research Branch, NIH/NIDA/IRP

Dr. Cadet is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Cadet's full profile

Already have an account?

Summary

  • Dr. Jean Cadet is a psychiatrist in Baltimore, MD. He received his medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 38 years. He also speaks multiple languages, including French and Creole. He specializes in addiction, neuropsychiatry, and psychopharmacology and is experienced in schizophrenia, brain, central nervous system stimulants, corpus striatum, and dopamine. He has more than 100 publications and over 500 citings.

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterResidency, Psychiatry, 1984 - 1987
  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Neurology, 1982 - 1984
  • New York Presbyterian Hospital (Columbia Campus)/New York State Psychiatric Institute
    New York Presbyterian Hospital (Columbia Campus)/New York State Psychiatric InstituteResidency, Psychiatry, 1980 - 1982
  • Atlantic Health System
    Atlantic Health SystemInternship, Transitional Year, 1979 - 1980
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1979

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1994 - 2022
  • American Board of Psychiatry and Neurology Psychiatry

Awards, Honors, & Recognition

  • NIH Director's Harvey Bullock, Jr. Award NIH, 2013

Publications & Presentations

PubMed

Press Mentions

  • My Quest for Sadness
    My Quest for SadnessOctober 13th, 2020

Grant Support

  • Protective Effects Of DA Antagonists V METH Induced Toxicity In RatsNational Institute On Drug Abuse2009–2011
  • Neurotoxicity In The Adult RAT Following Chronic Exposure To MethamphetamineNational Institute On Drug Abuse2009–2011
  • Methamphetamine Administration Causes Death Of Dopaminergic Neurons In The MouseNational Institute On Drug Abuse2009–2011
  • CDNA Array Analysis Of Cu/Zn SOD TG Mice Treated With Neurotoxic Doses Of AMPHNational Institute On Drug Abuse2009–2011
  • Neurological Assessments Of Marijuana Users.National Institute On Drug Abuse2009
  • Serial Analysis Of Gene Expression In The RAT Striatum Following MethamphetamineNational Institute On Drug Abuse2007–2008
  • Neurological Assessments Of Marijuana Users.National Institute On Drug Abuse2007–2008
  • Methamphetamine Administration Causes Death Of Dopaminergic Neurons In The MouseNational Institute On Drug Abuse2007–2008
  • METH Causes Alterations In The MAP Kinase-Related Pathways In The Brains Of MiceNational Institute On Drug Abuse2007–2008
  • CDNA Array Analysis Of Cu/Zn SOD TG Mice Treated With Neurotoxic Doses Of AMPHNational Institute On Drug Abuse2007–2008
  • Dose-Related Neurocognitive Effects Of Marijuana UseNational Institute On Drug Abuse2003–2007
  • CDNA Array Analysis Of Cu/Zn SOD TG Mice Treated With NENational Institute On Drug Abuse2003–2006
  • CDNA Array Analysis Of Cu/Zn SOD TG Mice Treated W/ AMPHNational Institute On Drug Abuse2005
  • Analysis Of Ecstasy (Mdma)-Induced TranscriptionNational Institute On Drug Abuse2005
  • Analysis Of Ecstasy (Mdma)-Induced Transcriptional RespoNational Institute On Drug Abuse2003–2004
  • Methamphetamine Causes Widespread Apoptosis In The MouseNational Institute On Drug Abuse2002
  • Methamphetamine Causes Differential Regulation In BCL-2National Institute On Drug Abuse2002
  • Molecular Neurotoxicological Models Of ParkinsonismNational Institute On Drug Abuse2001–2002
  • Methamphetamine Causes Widespread ApoptosisNational Institute On Drug Abuse2001
  • Methamphetamine Causes Differential Regulation Of BCL2National Institute On Drug Abuse2001
  • Gender Differences In The EEG Of Abstinent Cocaine Abusers.National Institute On Drug Abuse2000
  • Direct Interactions Of Methamphetamine With The Nucleus.National Institute On Drug Abuse2000
  • Caffeine Withdrawal Increases Blood Flow And Alters EEG ActivityNational Institute On Drug Abuse2000
  • Cocaine And Limbic Prefrontal Cortical FunctionNational Center For Research Resources2000
  • Overexpression Of Human Cu/Zn SOD In TG Mice Attenuates Oxidative Stress By MDMANational Institute On Drug Abuse1998–1999
  • Neurovascular Deficits In Cocaine AbusersNational Institute On Drug Abuse1998–1999
  • Dose-Related Neurobehavioral Effects Of Chronic Cocaine UseNational Institute On Drug Abuse1998–1999
  • Toxicity Of Amphetamine AnalogsNational Institute On Drug Abuse1996–1997
  • Neuropsychiatric Evaluation Of Drug Using HIV Positive/Negative IndividualsNational Institute On Drug Abuse1996–1997
  • Mechanisms Of Cell Death Caused By MethamphetamineNational Institute On Drug Abuse1996–1997
  • Role Of P53 In Methamphetamine Induced Neurotoxicity In MiceNational Institute On Drug Abuse1996
  • The Neuropsychiatric Evaluation Of HIV Positive Drug Using IndividualsNational Institute On Drug Abuse1995
  • Free Radicals On Opioid Receptor FunctionNational Institute On Drug Abuse1995

Committees

  • Co-chair of scientific committee, Society of Haitian Neuroscients 2021 - Present

Professional Memberships

  • Society for Neuroscience
    Member
  • Society for Biological Psychiatry
    Member

Other Languages

  • French, Creole